Florida legislation · 2026 Regular Session
Florida S860: Compounded Drugs
Status: Failed, March 13, 2026
Defining the term "compounded medication"; prohibiting any person or entity from engaging in the sale, transfer, or distribution of compounded medications for weight loss unless they provide specified documentation to the Department of Business and Professional Regulation; providing administrative penalties, etc.
What the bill says
An act relating to compounded drugs; creating s. 499.038, F.S.; defining the term "compounded medication"; prohibiting any person or entity from engaging in the sale, transfer, or distribution of compounded medications for weight loss unless they provide specified documentation to the Department of Business and Professional Regulation; providing administrative penalties; authorizing the department to adopt rules and conduct inspections as necessary to implement specified provisions; providing an effective date.
From the introduced text, December 10, 2025:
A bill to be entitled An act relating to compounded drugs; creating s. 499.038, F.S.; defining the term "compounded medication"; prohibiting any person or entity from engaging in the sale, transfer, or distribution of compounded medications for weight loss unless they provide specified documentation to the Department of Business and Professional Regulation; providing administrative penalties; authorizing the department to adopt rules and conduct inspections as necessary to implement specified provisions; providing an effective date. WHEREAS, the Legislature finds that the safety and integrity of compounded medications are paramount for the health and well-being of the residents of this state, and WHEREAS, the Legislature recognizes that while the United States Food and Drug Administration (FDA) sets internationally recognized standards for drug approval and regulatory oversight, there have been increasing attempts by bad actors to circumvent these regulations, undermining public trust and patient safety, and WHEREAS, the Legislature further finds that foreign entities, including those from countries such as China, have exploited regulatory gaps to introduce inferior or contaminated active pharmaceutical ingredients into the supply chain for medications intended for compounding, and WHEREAS, recent cases, including those involving medications for weight loss, have demonstrated that high demand can lead to the proliferation of the use of illicit, substandard, and potentially harmful active pharmaceutical ingredients that jeopardize patient health and safety, and WHEREAS, …
Sponsors
- Bradley, Jennifer (R, SD-006) · primary sponsor
Latest actions
- : Died in Regulated Industries
- : Introduced
- : Referred to Regulated Industries; Appropriations Committee on Agriculture, Environment, and General Government; Fiscal Policy
- : Filed
Subjects: Fiscal Policy, Appropriations Committee on Agriculture, Environment, and General Government, Regulated Industries
Common questions
- What is S860?
- S860 is a bill in the Florida Legislature (2026 Regular Session): Compounded Drugs.
- What does S860 do?
- In its own words: An act relating to compounded drugs; creating s. 499.038, F.S.; defining the term "compounded medication"; prohibiting any person or entity from engaging in the sale, transfer, or distribution of compounded medications for weight loss unless they provide specified documentation to the Department of Business and Professional Regulation; providing administrative penalties; authorizing the department to adopt rules and conduct inspections as necessary to implement specified provisions; providing an effective date.
- What is the status of S860?
- Failed as of March 13, 2026. Latest action: Died in Regulated Industries (March 13, 2026).
- Who sponsored S860?
- Bradley, Jennifer (R, SD-006).
- Where is the official record for S860?
- On the Florida Legislature website: https://www.flsenate.gov/Session/Bill/2026/860
Source: official Florida record. Tracked by Delilah, AI for legislation across all 50 states and Congress.